360 ONE Asset Acquires Minority Stake in House of Diagnostics

The fresh capital will be used to accelerate HOD’s business expansion in Tier-1 cities, beginning with Mumbai, and to scale its diagnostic offerings across pathology, radiology, and nuclear medicine.

Private equity and venture capital firm 360 ONE Asset has acquired a minority stake in Delhi-based diagnostics chain House of Diagnostics (HOD), as the company looks to expand its presence across major urban healthcare markets in India. 

Financial details of the transaction, including the size of the investment and stake acquired, were not disclosed.

The fresh capital will be used to accelerate HOD’s business expansion in Tier-1 cities, beginning with Mumbai, and to scale its diagnostic offerings across pathology, radiology, and nuclear medicine. The company is also planning to enter other large diagnostic markets, including Hyderabad and Bengaluru, as part of its next growth phase.

House of Diagnostics, which has been bootstrapped since its inception, said the partnership with 360 ONE Asset marks a strategic step to support long-term expansion plans. “Having bootstrapped the business since inception, we believe this is the right stage to bring on a long-term institutional partner to accelerate our next phase of growth,” said Dr Shubham Sogani, CEO of House of Diagnostics.

He added that the investment would enable the company to strengthen its footprint in key metropolitan markets while deepening its business-to-consumer (B2C) engagement. “This partnership with 360 ONE Asset gives us long-term capital and will use this investment to expand into new Tier-1 cities, beginning with Mumbai, and deepen our B2C engagements,” Sogani said.

Founded in 2007, House of Diagnostics is an integrated diagnostics chain with a strong presence in North India. The company currently operates 12 diagnostic centres and more than 200 collection centres, along with home sample collection services. Its service portfolio spans pathology testing, advanced imaging, and nuclear medicine diagnostics.

The investment comes at a time when diagnostic service providers are seeing increased demand in urban markets, driven by rising preventive healthcare adoption and the growing role of diagnostics in clinical decision-making. Expansion into Tier-1 cities is expected to place HOD in closer competition with established national diagnostic chains operating across metro regions.

360 ONE Asset’s minority investment signals continued investor interest in the diagnostics segment, which has remained active amid broader healthcare consolidation and capacity expansion trends. The transaction is expected to support House of Diagnostics’ efforts to scale operations while maintaining its integrated diagnostics model across new markets.

Stay tuned for more such updates on Digital Health News